Table 1.
Demographics by recipient race
| VARIABLE | WHITE RECIPIENTS (N=364) | BLACK RECIPIENTS (N=105) | P-value |
|---|---|---|---|
| Recipient Age | 52.4± 7.8 | 51.8 ± 6.8 | NS |
| Recipient Female Gender | 24.7% | 33.3% | 0.08 |
| Recipient BMI | 28.4 ± 5.4 | 29.1 ± 6.2 | NS |
| Recipient Albumin | 2.9 ± 0.6 | 2.5 ± 0.7 | <0.001 |
| Recipient Creatinine | 1.5 ± 1.2 | 2.1 ± 2.4 | <0.001 |
| Hepatocellular Carcinoma | 20.8% | 18.0% | NS |
| Alcohol cirrhosis co-morbidity | 44.5% | 43.1% | NS |
| HBV (Surface Antigen positive) | 2.1% | 2.0% | NS |
| Recipient Diabetes | 22.0% | 23.0% | NS |
| % living related transplant | 5.8% | 5.7% | NS |
| Combined Kidney Transplant | 4.4% | 14.3% | 0.001 |
| Anti-Lymphocyte Induction | 33.5% | 53.0% | <0.001 |
| Recipient pre-transplant log viral load | 5.6 ± 0.9 (N=134) | 5.3 ± 1.4 (N=42) | 0.08 |
| % treated for HCV recurrence post LT | 34.6% | 30.5% | NS |
| % treated for acute rejection in 1st two years | 25.0% | 28.6% | NS |
| Donation after cardiac death | 3.0% | 1.2% | NS |
| Cold Ischemia Time (In hours) | 6.7 ± 2.5 | 7.3 ± 5.1 | 0.2 |
| Donor Age | 39.2 ± 15.1 | 38.1 ± 15.5 | NS |
| Donor Female Gender | 64.0% | 61.0% | NS |
| Donor Race (% B/W) | 86.4%/13.7% | 67.6%/32.4% | <0.001 |
| CMV High Risk (D+/R−) | 20.2% | 8.9% | 0.01 |
BMI: body mass index; HCV: Hepatitis C Virus; LT: Liver Transplantation; B/W: Black/White; D+/R−: Donor positive, recipient negative; NS: Non-significant